The CRISPR Journal

Editor-in-Chief: Rodolphe Barrangou, PhD

ISSN: 2573-1599 | Online ISSN: 2573-1602 | Published Bimonthly | Current Volume: 3

Impact Factor: 5.343 2019 Journal Citation Reports (Clarivate, 2020)

The only peer-reviewed journal dedicated to the science and applications of gene editing.

View Aims & Scope

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

Announcements

CALL FOR PAPERS
CRISPR in CHINA
Congratulations Editorial Board Members Jennifer Doudna and Emmanuelle Charpentier on winning the Nobel Prize!

New Podcast Series! Essentials of CRISPR-based Animal Models in Drug Discovery

Episode #1: Choosing the Best Genetic Modification Technology to Generate an Animal Model...Listen Now on Acast or on your favorite podcast app.

Free Webinars On Demand

Base Editing: Putting Precision into Genomic Medicine - Watch Now
CRISPR-Based In Vivo Genome Editing and Base Editing - Watch Now
A CRISPR Vision for the Future of Cell Therapy - Watch Now
CRISPR GuidePost Podcast Series

Exclusive interviews with the pioneers of CRISPR research and genome editing. Check out previous episodes here or listen now on your favorite podcast app.

Visit the Horizon CRISPR Learning Center, including:

      Podcast Miniseries on CRISPR Functional Genomics
      Webinar on CRISPR Screening: From target selection to patient stratification
      Expert Panel Discussion on Best Practices & Challenges in CRISPR Screening

Free eNewsletter: Briefings in CRISPR and Gene Editing

Sign Up

Aims & Scope

At the Cutting-Edge of Genome Editing

The CRISPR Journal is the only peer-reviewed publication dedicated to the science and applications of gene editing. Spearheaded by Editor-in-Chief Rodolphe Barrangou, PhD and aided by a diverse and accomplished editorial board, the Journal provides a high-profile forum for cutting-edge international original research papers, as well as a compelling mixture of frontmatter content— review articles, perspectives, profiles, and commentary spanning not only matters of research but the many social, ethical, and business issues confronting the field. The CRISPR Journal centralizes essential information and analysis on this revolutionary technology in a single location with the aim of solidifying and growing the community of innovative researchers, practitioners, policymakers, and activists who make up the field of gene editing.

The CRISPR Journal coverage includes:

CRISPR biology and technology
Host-pathogen interactions
Microbial immunity
Genetic diseases
DNA-protein complexes
Gene therapy
Base editing
Cancer immunotherapy
Embryonic development
Bioinformatics
Synthetic biology
Systems biology
CRISPR-Cas evolution
Animal models
Organ transplantation
Gene drives
Plant biology
Food science
Genetically modified foods
Bioethics
IP and patenting
Conservation
Genome editing technology (Zinc fingers and TALENs)

Indexed/Abstracted in:

PubMed/MEDLINE
PubMed Central
Current Contents®/Life Sciences
Science Citation Index Expanded
Biological Abstracts
Journal Citation Reports/Science Edition
EMBASE/Excerpta Medica
Scopus

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.